Janux Therapeutics, Inc. - COM (JANX)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
49
Total Shares
29M
Shares change
-586K
Total reported value, excl. options
$381M
Value change
-$7.76M
Put/Call ratio
0.03
Number of buys
25
Number of sells
-16
Price
$13.17
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.